Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects with Treatment Resistant Herpes Simplex Virus Type 1 or 2
Clinical trial NCT05844436 · AVAILABLE
Trial details
- NCT number
- NCT05844436
- Sponsor
- AiCuris Anti-infective Cures AG
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.